KomFi. Academy

hard · GMAT Verbal Reasoning

A pharmaceutical company claims that its new drug, Claritex, is more effective at treating chronic insomnia than the current leading medication, Somnium. In a clinical trial, 75% of patients taking Claritex reported sleeping more than seven hours per night, whereas only 60% of patients taking Somnium reported the same.

Which of the following would be most useful to know in order to evaluate the company's claim?

  1. Whether Claritex has received regulatory approval for use in countries other than the one where the trial was conducted.
  2. How many of the patients in the trial had previously used other insomnia medications without success.
  3. The total number of patients who participated in the clinical trial for Claritex.
  4. The retail price the company intends to charge for a thirty-day supply of Claritex compared to the price of Somnium.
  5. Whether the Claritex group had less severe insomnia on average before the trial than the Somnium group.

Sign up free to see the explanation and track your rank →

More GMAT Verbal Reasoning practice

All Verbal Reasoning questions · GMAT study guide · GMAT glossary · GMAT flashcards